James Topper, M.D., Ph.D.
Board Member
Phathom Pharmaceuticals, Inc. (PHAT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Topper, M.D., Ph.D.
James Topper, M.D., Ph.D. is recorded as Board Member at Phathom Pharmaceuticals, Inc. (PHAT). Phathom Pharmaceuticals, Inc. reported in an 8-K filed September 26, 2022 that James Topper, M.D., Ph.D. was appointed Class III director, effective September 22, 2022.
“On September 22, 2022, the board of directors (the "Board") of Phathom Pharmaceuticals, Inc. (the "Company") appointed James Topper, M.D., Ph.D. to the Board as a Class III director, effective immediately, with an initial term expiring at the 2025 annual meeting of stockholders of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Phathom Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Steven Basta CEO, Board Member
- Steven L. Basta CEO, Board Member
- Anthony Guzzo CFO, Chief Accounting Officer
- Sanjeev Narula CFO
- Todd Branning CFO
- Todd P. Branning CFO
- Azmi Nabulsi COO
- Asit Parikh Board Member
- Asit Parikh, M.D., Ph.D. Board Member
- Frank Karbe Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.